EUVIMEDEUVIMED entdecken
Crossref

Developing a Serum-Free and Cytokine-Optimizing Induction Medium to Increase the Production of CD14 + CD16 + and CD14 + CD16 − Monocytes from Human CD133 + Hematopoietic Stem and Progenitor Cells

Tsung-Yu Tseng, Yi-Ting Lai, Yun Chen, Hsing-Fen Tsai, Keng-Fu Hsu, Shu-Ching Hsu, Chao-Ling Yao iD

Stem Cells and Development · 2025

DOI: 10.1089/scd.2024.0143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells and Development, 2025. Verfasst von Tsung-Yu Tseng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, National Cheng Kung University, Tainan City, Taiwan. Hauptthemen laut MEDLINE: Receptors, IgG, Monocytes, Hematopoietic Stem Cells, Lipopolysaccharide Receptors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy utilizes immune cells to target cancer and improves treatment outcomes with few side effects. Despite the effectiveness of immunotherapy, the limited availability of monocytes, which are essential for the differentiation of antigen-presenting cells, remains a major challenge. In this study, we developed a technique for inducing monocytes from hematopoietic stem and progenitor cells by using a serum-free (SF) medium supplemented with optimal concentrations of serum substitutes and cytokines. Three key serum substitutes, namely lipids, ascorbic acid, and β-glycerophosphate, were identified through factorial design screening, with their concentrations optimized through steepest ascent path analysis. Iscove’s modified Dulbecco’s medium was identified as the optimal basal medium. Long-term culturing confirmed the successful induction of CD14 + CD16 + and CD14 + CD16 − monocytes. Functional assays validated the efficacy of this technique with comparable gene expression, cytokine secretion, phagocytosis ability, and T-cell stimulating ability between SF and serum-containing cultures. Under SF conditions, high expression levels of CD16 were detected, indicating the broad range of potential applications of CD16 + monocytes. Overall, this technique represents a feasible SF alternative for monocyte generation, with potential benefits for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, IgGMonocytesHematopoietic Stem CellsLipopolysaccharide ReceptorsCytokinesCell Culture TechniquesHumansCulture Media, Serum-FreeCell DifferentiationGPI-Linked ProteinsCells, CulturedPhagocytosis

Stichwörter der Autor:innen

cytokinehematopoietic stem and progenitor cellimmunotherapyinductionmonocyteserum-free

Substanzen

Receptors, IgGLipopolysaccharide ReceptorsCytokinesCulture Media, Serum-FreeGPI-Linked ProteinsCD14 protein, humanFCGR3B protein, human

Autor:innen und Institutionen

  • Department of Chemical Engineering, National Cheng Kung University, Tainan City, Taiwan.
  • Department of Chemical Engineering and Materials Science, Yuan Ze University, Taoyuan City, Taiwan.
  • Graduate Institute of Medicine, Yuan Ze University, Taoyuan City, Taiwan.
  • Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, Tainan City, Taiwan.
  • College of Medicine, National Cheng Kung University, Tainan City, Taiwan.

ORCID-Profile: Chao-Ling Yao

Zitieren

APA

Tseng, T. Y., Lai, Y. T., Chen, Y., Tsai, H. F., Hsu, K. F., Hsu, S. C., & Yao, C. L. (2025). Developing a Serum-Free and Cytokine-Optimizing Induction Medium to Increase the Production of CD14 + CD16 + and CD14 + CD16 − Monocytes from Human CD133 + Hematopoietic Stem and Progenitor Cells. Stem Cells and Development. https://doi.org/10.1089/scd.2024.0143

Vancouver

Tseng TY, Lai YT, Chen Y, Tsai HF, Hsu KF, Hsu SC, et al. Developing a Serum-Free and Cytokine-Optimizing Induction Medium to Increase the Production of CD14 + CD16 + and CD14 + CD16 − Monocytes from Human CD133 + Hematopoietic Stem and Progenitor Cells. Stem Cells and Development. 2025. doi:10.1089/scd.2024.0143

BibTeX
@article{Tseng2025,
  author = {Tseng, Tsung-Yu and Lai, Yi-Ting and Chen, Yun and Tsai, Hsing-Fen and Hsu, Keng-Fu and Hsu, Shu-Ching and Yao, Chao-Ling},
  title = {Developing a Serum-Free and Cytokine-Optimizing Induction Medium to Increase the Production of CD14 + CD16 + and CD14 + CD16 − Monocytes from Human CD133 + Hematopoietic Stem and Progenitor Cells},
  journal = {Stem Cells and Development},
  year = {2025},
  doi = {10.1089/scd.2024.0143}
}
Kostenlos starten →